Extra provider scrutiny is warranted for patients with hepatic impairment (Child-Pugh B or C), significant renal impairment (eGFR below 30), high-dose zinc supplementation (above 50 mg/day), active infection at the intended injection site, or age under 18
The panel's vote is not binding but is likely to embolden Health Secretary Robert F
This BPC-157 TB-500 combo eliminates the need for separate peptide applications, significantly reducing TB-500 cost while maximizing research efficiency
The peptide backbone protects the copper center and still allows it to interact selectively with biological targets
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations